KDM1A and cancer: We have previously shown that LSD1 could target gene induction programs promoting epithelial to mesenchymal transition (EMT) and cancer stem cells (CSC) and that inhibition of LSD1 suppresses chemotherapy-induced EMT and cancer associated fibroblasts (CAFs) (22).